Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Roger Brüggemann

Researcher
 
 
  • Comment on

    • nov. 2022
    • Beatrijs, Mertens, et al
    • Journal of Antimicrobial Chemotherapy
  • Liposomal amphotericin B-the past

    • nov. 2022
    • R. J., Brüggemann, et al
    • Journal of Antimicrobial Chemotherapy
  • Impact of mucositis on oral bioavailability and systemic exposure of ciprofloxacin Gram-negative infection prophylaxis in patients with haematological malignancies

    • okt. 2022
    • K. P., van Rhee, et al
    • Journal of Antimicrobial Chemotherapy
  • Risk-proportionate approach to paediatric clinical trials

    • okt. 2022
    • Mandy, Wan, et al
    • Clinical Trials
  • An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients

    • sep. 2022
    • Eveline, Wallenburg, et al
    • Clinical Pharmacokinetics
View all publications